All News

A blood test may help to identify a subset of patients with mantle cell lymphoma and determine the management of outcomes of these individuals.

While cancer can strip or challenge our life roles and identity, I hope we all remember that we are more than a patient, more than a statistic, and that we can learn something new about ourselves.

After two of my oncologists retired, I had to search for the next one.

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

When Paul Isenberg’s wife, Nicole, was diagnosed with stage 4 Hodgkin lymphoma shortly after the birth of their child, Gabrielle, the couple realized two things: how blessed they were and that some people going through cancer have nobody to turn to.

A high dose of precision radiation could drastically increase the survival rates of patients with metastatic cancer, and double the time patients live without cancer growth, according to study results presented at the 60th Annual Meeting of the American Society for Radiation Oncology.

In a recent survey, individuals in remission reported a more positive experience with bladder cancer compared with their counterparts who currently have active disease.

Breast cancer survivor who had treatment years ago discusses her new breast cancer choices today.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

While universal screening for Lynch syndrome is currently only recommended for patients with colorectal and endometrial cancers, a new study recently published in The American Journal of Surgical Pathology suggests this for patients with upper tract urothelial carcinoma, too.

Patients with head and neck cancer appeared to be receptive to lung cancer screening, according to recent research performed at the University of Iowa Hospitals and Clinics.

I'm using the lessons that cancer taught me to move forward in life.

When mental health and cancer health merge

Choosing to connect with other patients doesn't come without loss, but the benefit of being empowered by others makes you a better patient and more impassioned survivor.

Cancer survivors learn to tunnel through the snow. We have a community to help us become stronger mentally and support us through the tough times.

Explaining what lymhedema feels like isn't always easy.

We spend so much time worrying what we can't control. What if we asked ourselves why and changed the thought process to worrying about only what we can control.

Imagine receiving two pieces of life-altering news in a matter of three days. One survivor not only experienced this, but came out the other side with a positive outlook and a humorous book, too.

From sugar to stress, are there really any lifestyle changes that can truly keep cancer at bay?

As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.

The FDA has granted a priority designation to a supplemental new drug application (sNDA) for Imbruvica (ibrutinib) for use in combination with Gazyva (obinutuzumab) for the frontline treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

The amount of preventative medicines given during hospital admission may be associated with an increased amount prescribed at discharge – resulting in higher costs and an increased risk for drug-drug interactions in patients with advanced lung cancer.

As marijuana use continues to increase across the US – and become legalized in more states – understanding the potential negative health effects is paramount.

Patients with the disease reported increased feelings of stigmatization, and results also showed that patients are viewed or treated differently than those with other cancer types.

With this FDA action, Talzenna (talazoparib) is the second PARP inhibitor to be approved in the breast cancer space.

In the first such clinical trial in the United States, researchers will evaluate focused ultrasound to breach the blood-brain barrier

More than 20 percent of patients with non–clear cell renal cell carcinoma (RCC) had a germline mutation, of which half had the potential to direct systemic therapy.

Experts at Roswell Park Comprehensive Cancer Center discovered a way to assess if a kidney tumor is benign or malignant, potentially sparing many from having to undergo surgery.